General Information of the Compound
Compound ID
CP0745157
Compound Name
4-(3-((7-methoxyquinolin-4-yloxy)methyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)-Nmethylbenzamide
    Show/Hide
Structure
Formula
C20H17N5O2
Molecular Weight
359.389
Canonical SMILES
CNC(=O)c1ccc(-c2ccc3nnc(Cc4ccc(O)cc4)n3n2)cc1
    Show/Hide
InChI
InChI=1S/C20H17N5O2/c1-21-20(27)15-6-4-14(5-7-15)17-10-11-18-22-23-19(25(18)24-17)12-13-2-8-16(26)9-3-13/h2-11,26H,12H2,1H3,(H,21,27)
    Show/Hide
InChIKey
RLSBXOCXRAXJST-UHFFFAOYSA-N
Physicochemical Property
logP
2.4473
Rotatable Bonds
4
Heavy Atom Count
27
Polar Areas
92.41
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
6
Complexity
27

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44576884
ChEMBL ID
CHEMBL494983
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01201, Hepatocyte growth factor receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL001061 PC-2 [Human pancreatic carcinoma China] Homo sapiens (Human)  1
1
IC50 = 16 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 6 nM